
Michael D. Pak
Examiner (ID: 3628, Phone: (571)272-0879 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1674, 1621, 1646, 1812, 0 |
| Total Applications | 1549 |
| Issued Applications | 718 |
| Pending Applications | 268 |
| Abandoned Applications | 570 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6001704
[patent_doc_number] => 20110117574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'FLUORESCENCE BASED ASSAY TO DETECT SODIUM/CALCIUM EXCHANGER \"FORWARD MODE\" MODULATING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/922749
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5851
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117574.pdf
[firstpage_image] =>[orig_patent_app_number] => 12922749
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922749 | FLUORESCENCE BASED ASSAY TO DETECT SODIUM/CALCIUM EXCHANGER "FORWARD MODE" MODULATING COMPOUNDS | Mar 12, 2009 | Abandoned |
Array
(
[id] => 6566502
[patent_doc_number] => 20100234274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Use of Nestafin-1 in the Treatment for Diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/402848
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5883
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234274.pdf
[firstpage_image] =>[orig_patent_app_number] => 12402848
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/402848 | Use of Nestafin-1 in the Treatment for Diabetes | Mar 11, 2009 | Abandoned |
Array
(
[id] => 7778348
[patent_doc_number] => 20120040938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'GLUCOCORTICOID RECEPTOR ALLELES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/254338
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18207
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040938.pdf
[firstpage_image] =>[orig_patent_app_number] => 13254338
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/254338 | GLUCOCORTICOID RECEPTOR ALLELES AND USES THEREOF | Mar 3, 2009 | Abandoned |
Array
(
[id] => 6185053
[patent_doc_number] => 20110124006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'METHOD FOR SCREENING OF THERAPEUTIC AGENT FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/921015
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 9052
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124006.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921015
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921015 | METHOD FOR SCREENING OF THERAPEUTIC AGENT FOR CANCER | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6175778
[patent_doc_number] => 20110177502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/735843
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29433
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177502.pdf
[firstpage_image] =>[orig_patent_app_number] => 12735843
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735843 | IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY DISEASE LOCI AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME | Feb 18, 2009 | Abandoned |
Array
(
[id] => 5480666
[patent_doc_number] => 20090203623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/368935
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20763
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368935
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368935 | METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST | Feb 9, 2009 | Abandoned |
Array
(
[id] => 5385711
[patent_doc_number] => 20090226956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'RUNX-MEDIATED ACTION OF NUCLEAR RECEPTORS AND UTILITIES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/367493
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32652
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226956.pdf
[firstpage_image] =>[orig_patent_app_number] => 12367493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/367493 | RUNX-MEDIATED ACTION OF NUCLEAR RECEPTORS AND UTILITIES THEREOF | Feb 5, 2009 | Abandoned |
Array
(
[id] => 9850016
[patent_doc_number] => 08951742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof'
[patent_app_type] => utility
[patent_app_number] => 12/363932
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19487
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12363932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/363932 | Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof | Feb 1, 2009 | Issued |
Array
(
[id] => 5458271
[patent_doc_number] => 20090258423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Cell cycle regulation and differentiation'
[patent_app_type] => utility
[patent_app_number] => 12/321952
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 105
[patent_figures_cnt] => 105
[patent_no_of_words] => 32082
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258423.pdf
[firstpage_image] =>[orig_patent_app_number] => 12321952
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321952 | Cell cycle regulation and differentiation | Jan 25, 2009 | Issued |
Array
(
[id] => 5354682
[patent_doc_number] => 20090186026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'EPHRIN AND EPH RECEPTOR AGONISTS FOR MODULATION OF BONE FORMATION AND RESORPTION'
[patent_app_type] => utility
[patent_app_number] => 12/354892
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13602
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186026.pdf
[firstpage_image] =>[orig_patent_app_number] => 12354892
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/354892 | EPHRIN AND EPH RECEPTOR AGONISTS FOR MODULATION OF BONE FORMATION AND RESORPTION | Jan 15, 2009 | Abandoned |
Array
(
[id] => 7586769
[patent_doc_number] => 20110281279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'CIRCULATING Epha2 RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/808470
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7858
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281279.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808470
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808470 | CIRCULATING Epha2 RECEPTOR | Dec 16, 2008 | Abandoned |
Array
(
[id] => 8772195
[patent_doc_number] => 08426147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-23
[patent_title] => 'RORS as modifiers of the p21 pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/325914
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15866
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12325914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/325914 | RORS as modifiers of the p21 pathway and methods of use | Nov 30, 2008 | Issued |
Array
(
[id] => 6264683
[patent_doc_number] => 20100297615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'EGFR MUTATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/272321
[patent_app_country] => US
[patent_app_date] => 2008-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8920
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297615.pdf
[firstpage_image] =>[orig_patent_app_number] => 12272321
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/272321 | EGFR mutations | Nov 16, 2008 | Issued |
Array
(
[id] => 6234900
[patent_doc_number] => 20100266604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'USE OF TAM RECEPTOR INHIBITORS AS IMMUNOENHANCERS AND TAM ACTIVATORS AS IMMUNOSUPPRESSORS'
[patent_app_type] => utility
[patent_app_number] => 12/741797
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 43206
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266604.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741797
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741797 | USE OF TAM RECEPTOR INHIBITORS AS IMMUNOENHANCERS AND TAM ACTIVATORS AS IMMUNOSUPPRESSORS | Nov 6, 2008 | Abandoned |
Array
(
[id] => 5434957
[patent_doc_number] => 20090169543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Method for regulating immune function in primates using the Foxp3 protein'
[patent_app_type] => utility
[patent_app_number] => 12/291359
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23976
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169543.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291359 | Method for regulating immune function in primates using the Foxp3 protein | Nov 5, 2008 | Abandoned |
Array
(
[id] => 5391237
[patent_doc_number] => 20090208550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Methods and compositions for treating hepatic diseases'
[patent_app_type] => utility
[patent_app_number] => 12/290021
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20969
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208550.pdf
[firstpage_image] =>[orig_patent_app_number] => 12290021
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/290021 | Methods and compositions for treating hepatic diseases | Oct 23, 2008 | Abandoned |
Array
(
[id] => 7663653
[patent_doc_number] => 20110312922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'EDTA Resistant S100A12 Complexes (ERAC)'
[patent_app_type] => utility
[patent_app_number] => 12/738579
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19841
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312922.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738579 | EDTA Resistant S100A12 Complexes (ERAC) | Oct 16, 2008 | Abandoned |
Array
(
[id] => 6439188
[patent_doc_number] => 20100279314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX'
[patent_app_type] => utility
[patent_app_number] => 12/738257
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11976
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279314.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738257
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738257 | COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX | Oct 14, 2008 | Abandoned |
Array
(
[id] => 6347974
[patent_doc_number] => 20100330697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/738337
[patent_app_country] => US
[patent_app_date] => 2008-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16840
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330697.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738337
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738337 | COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME | Oct 13, 2008 | Abandoned |
Array
(
[id] => 5422395
[patent_doc_number] => 20090148850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'Methods for identifying modulators of P2RY14'
[patent_app_type] => utility
[patent_app_number] => 12/286566
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 8326
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148850.pdf
[firstpage_image] =>[orig_patent_app_number] => 12286566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/286566 | Methods for identifying modulators of P2RY14 | Sep 30, 2008 | Abandoned |